Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Prophase Labs Inc
(NQ:
PRPH
)
2.450
-0.240 (-8.92%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 26, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
25,862
Open
2.660
Bid (Size)
2.120 (3)
Ask (Size)
2.500 (2)
Prev. Close
2.690
Today's Range
2.420 - 2.700
52wk Range
2.040 - 7.480
Shares Outstanding
18,045,209
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
PRPH Stock Earnings: ProPhase Labs Misses EPS, Misses Revenue for Q2 2024
August 14, 2024
PRPH stock results show that ProPhase Labs missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024.
Via
InvestorPlace
PRPH Stock Earnings: ProPhase Labs Beats EPS, Misses Revenue for Q1 2024
May 09, 2024
PRPH stock results show that ProPhase Labs beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024.
Via
InvestorPlace
Performance
YTD
-47.20%
-47.20%
1 Month
-20.97%
-20.97%
3 Month
-52.15%
-52.15%
6 Month
-51.77%
-51.77%
1 Year
-51.39%
-51.39%
More News
Read More
PRPH Stock Earnings: ProPhase Labs Misses EPS, Misses Revenue for Q4 2023
March 15, 2024
Via
InvestorPlace
Earnings Scheduled For March 15, 2024
March 15, 2024
Via
Benzinga
ProPhase Labs's Earnings: A Preview
March 14, 2024
Via
Benzinga
ProPhase Labs Earnings Preview
November 08, 2023
Via
Benzinga
Analyst Expectations for ProPhase Labs's Future
May 12, 2023
Via
Benzinga
Recap: ProPhase Labs Q1 Earnings
May 11, 2023
Via
Benzinga
Overview Of Value Stocks In The Healthcare Sector
April 10, 2023
Via
Benzinga
Stocks That Hit 52-Week Lows On Tuesday
August 29, 2023
Via
Benzinga
DSS, Inc.'s (NYSE American: DSS) Subsidiary Appoints New Chief Investment Officer To Aggressively Develop Mutual Fund Business For Eventual Spinoff
July 26, 2023
Via
Benzinga
DSS Inc. Is Spinning Off Its Biotech Subsidiary After Signing A Major Licensing Agreement
June 27, 2023
Via
News Direct
ProPhase Labs Earnings Preview
March 27, 2023
Via
Benzinga
A Look Into Healthcare Sector Value Stocks
January 23, 2023
Via
Benzinga
5 Value Stocks In The Healthcare Sector
January 09, 2023
Via
Benzinga
ProPhase Labs's Return On Capital Employed Overview
December 20, 2022
Via
Benzinga
Stocks That Hit 52-Week Lows On Friday
August 11, 2023
Via
Benzinga
DSS Inc. Is Spinning Off Its Biotech Subsidiary After Signing A Major Licensing Agreement
June 27, 2023
Via
TheNewswire.com
DSS Inc. Is Spinning Off Its Biotech Subsidiary After Signing A Major Licensing Agreement
June 26, 2023
Via
Benzinga
5 Value Stocks In The Healthcare Sector
December 05, 2022
Via
Benzinga
Earnings Scheduled For August 10, 2023
August 10, 2023
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
June 01, 2023
Via
Benzinga
7 Small-Cap Biotech Stocks with Massive Potential
April 27, 2023
Via
InvestorPlace
Impact Biomedical Preparing A Potential Spinoff — What Does This Mean For Investors Of Holding Company DSS, Inc (NYSE American: DSS)?
March 27, 2023
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
January 11, 2023
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.